These analyses suggest that trial design innovation may better control the placebo response and separate the treatment effect of suzetrigine from placebo in future studies, which Vertex will ...
Additionally, as previously announced, suzetrigine is under FDA review for the treatment of moderate-to-severe acute pain ... Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR) Study This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback